Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDDate | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
08/16/2023 | Q2 2023 | -$2.94 | $112,000 | |||
03/31/2023 | Q1 2023 | -$2.46 | $136,000 | |||
03/15/2023 | Q4 2022 | -$1.54 | $241,000 | |||
09/30/2022 | Q3 2022 | $7.00 | $3,000 | |||
06/30/2022 | Q2 2022 | -$1.01 | $157,000 | |||
03/30/2022 | Q1 2022 | -$3.41 | $0 | |||
03/17/2022 | Q4 2021 | -$5.51 | $238,000 | |||
09/29/2021 | Q3 2021 | $24.90 | $170,000 | |||
07/26/2021 | Q2 2021 | -$10.70 | $25,000 | |||
03/30/2021 | Q1 2021 | -$6.77 | $210,000 | |||
03/24/2021 | Q4 2020 | $5.70 | -$14.52 | -20.22 | $1.04 M | |
09/29/2020 | Q3 2020 | -$9.79 | $639,000 | |||
06/29/2020 | Q2 2020 | -$11.88 | $540,000 | |||
03/27/2020 | Q1 2020 | -$11.69 | $1.10 M | |||
03/20/2020 | Q4 2019 | -$6.14 | $-17,372,000 | |||
09/29/2019 | Q3 2019 | -$12.70 | $5.29 M | |||
06/29/2019 | Q2 2019 | -$81.22 | $8.75 M | |||
03/30/2019 | Q1 2019 | -$332.58 | $8.23 M | |||
12/30/2018 | Q4 2018 | -$1,238.90 | $10.60 M | |||
09/29/2018 | Q3 2018 | -$343.04 | $12.33 M |
Liminal BioSciences Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 7th, 2023 based off last year's report dates.
In the previous quarter, Liminal BioSciences Inc. (:LMNL) reported $2.3 earnings per share (EPS) to beat the analysts' consensus estimate of $1.7 by $0.6.
The conference call for Liminal BioSciences Inc.'s latest earnings report can be listened to online.
The conference call transcript for Liminal BioSciences Inc.'s latest earnings report can be read online.
Liminal BioSciences Inc. (:LMNL) has a recorded annual revenue of $401,000.
Liminal BioSciences Inc. (:LMNL) has a recorded net income of $401,000. Liminal BioSciences Inc. has generated $-9.32 earnings per share over the last four quarters.
Liminal BioSciences Inc. (:LMNL) has a price-to-earnings ratio of -1.31 and price/earnings-to-growth ratio is 0.01.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED